| Pharmaceutical active ingredients: |
| Exemestane |
| Available forms, composition and doses of Nikidess: |
| N / A |
| Nikidess medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L02BG06 - Exemestane |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nikardin | Nikethamide | Unidentified Pharmaceutical Company |
| Nikethan | Ethyl Nicotinate | Unidentified Pharmaceutical Company |
| Niketharol | Nikethamide | Unidentified Pharmaceutical Company |
| Nikethyl | Nikethamide | Unidentified Pharmaceutical Company |
| Niketilamid | Nikethamide | Unidentified Pharmaceutical Company |
| Nikithan | Ethyl Nicotinate | Unidentified Pharmaceutical Company |
| Nikkol | Laureth-9 | Unidentified Pharmaceutical Company |
| Nikodon | Nifenazone | Unidentified Pharmaceutical Company |
| Nikofezon | Nifenazone | Unidentified Pharmaceutical Company |
| Nikomet | Methyl Nicotinate | Unidentified Pharmaceutical Company |